Identification of adverse reactions that can occur on substitution of generic for branded lamotrigine in patients with epilepsy
- 28 February 2007
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 29 (2) , 334-341
- https://doi.org/10.1016/j.clinthera.2007.02.005
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Are there potential problems with generic substitution of antiepileptic drugs?Seizure, 2006
- Therapeutic equivalency of generic antiepileptic drugs: results of a surveyEpilepsy & Behavior, 2004
- Generic Substitution for Brand Name Antiepileptic Drugs: A SurveyCanadian Journal of Neurological Sciences, 2000
- Is Generic Prescribing Acceptable in Epilepsy?Drug Safety, 2000
- Generic prescribing for epilepsy. Is it safe?Seizure, 1996
- Loss of Seizure Control Associated with Generic Substitution of CarbamazepineAnnals of Pharmacotherapy, 1992
- Breakthrough seizure following substitution of Depakene capsules (Abbott) with a generic productNeurology, 1987
- Increased seizure frequency with generic primidonePublished by American Medical Association (AMA) ,1987
- Untoward Effects of Generic Carbamazepine TherapyArchives of Neurology, 1987
- Outbreak of Anticonvulsant Intoxication in an Australian CityBMJ, 1970